Literature DB >> 26178993

Simian Varicella Virus Is Present in Macrophages, Dendritic Cells, and T Cells in Lymph Nodes of Rhesus Macaques after Experimental Reactivation.

Vicki Traina-Dorge1, Lara A Doyle-Meyers2, Robert Sanford3, Jennifer Manfredo4, Anna Blackmon4, Mary Wellish4, Stephanie James4, Xavier Alvarez5, Cecily Midkiff5, Brent E Palmer6, Eileen Deharo1, Don Gilden7, Ravi Mahalingam8.   

Abstract

UNLABELLED: Like varicella-zoster virus (VZV), simian varicella virus (SVV) reactivates to produce zoster. In the present study, 5 rhesus macaques were inoculated intrabronchially with SVV, and 5 months later, 4 monkeys were immunosuppressed; 1 monkey was not immunosuppressed but was subjected to the stress of transportation. In 4 monkeys, a zoster rash developed 7 to 12 weeks after immunosuppression, and a rash also developed in the monkey that was not immunosuppressed. Analysis at 24 to 48 h after zoster revealed SVV antigen in the lung alveolar wall, in ganglionic neurons and nonneuronal cells, and in skin and in lymph nodes. In skin, SVV was found primarily in sweat glands. In lymph nodes, the SVV antigen colocalized mostly with macrophages, dendritic cells, and, to a lesser extent, T cells. The presence of SVV in lymph nodes, as verified by quantitative PCR detection of SVV DNA, might reflect the sequestration of virus by macrophages and dendritic cells in lymph nodes or the presentation of viral antigens to T cells to initiate an immune response against SVV, or both. IMPORTANCE: VZV causes varicella (chickenpox), becomes latent in ganglia, and reactivates to produce zoster and multiple other serious neurological disorders. SVV in nonhuman primates has proved to be a useful model in which the pathogenesis of the virus parallels the pathogenesis of VZV in humans. Here, we show that SVV antigens are present in sweat glands in skin and in macrophages and dendritic cells in lymph nodes after SVV reactivation in monkeys, raising the possibility that macrophages and dendritic cells in lymph nodes serve as antigen-presenting cells to activate T cell responses against SVV after reactivation.
Copyright © 2015, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26178993      PMCID: PMC4577922          DOI: 10.1128/JVI.01324-15

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

Review 1.  Autonomic innervation and regulation of the immune system (1987-2007).

Authors:  Dwight M Nance; Virginia M Sanders
Journal:  Brain Behav Immun       Date:  2007-04-27       Impact factor: 7.217

2.  Simian varicella virus pathogenesis.

Authors:  Ravi Mahalingam; Ilhem Messaoudi; Don Gilden
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

3.  Latent simian varicella virus reactivates in monkeys treated with tacrolimus with or without exposure to irradiation.

Authors:  Ravi Mahalingam; Vicki Traina-Dorge; Mary Wellish; Eileen Deharo; Morgan L Singletary; Erin P Ribka; Robert Sanford; Don Gilden
Journal:  J Neurovirol       Date:  2010-10       Impact factor: 2.643

4.  Varicella zoster viraemia during herpes zoster is not associated with neoplasia.

Authors:  G Bezold; M Lange; H Pillekamp; R U Peter
Journal:  J Eur Acad Dermatol Venereol       Date:  2002-07       Impact factor: 6.166

5.  Characterization of viremia at different stages of varicella-zoster virus infection.

Authors:  C Mainka; B Fuss; H Geiger; H Höfelmayr; M H Wolff
Journal:  J Med Virol       Date:  1998-09       Impact factor: 2.327

6.  T cells increase before zoster and PD-1 expression increases at the time of zoster in immunosuppressed nonhuman primates latently infected with simian varicella virus.

Authors:  Stephanie F James; Vicki Traina-Dorge; Eileen Deharo; Mary Wellish; Brent E Palmer; Don Gilden; Ravi Mahalingam
Journal:  J Neurovirol       Date:  2014-02-19       Impact factor: 2.643

7.  Simian varicella virus reactivation in cynomolgus monkeys.

Authors:  Ravi Mahalingam; Vicki Traina-Dorge; Mary Wellish; Rebecca Lorino; Robert Sanford; Erin P Ribka; Scott J Alleman; Elizabeth Brazeau; Donald H Gilden
Journal:  Virology       Date:  2007-07-24       Impact factor: 3.616

8.  T-cell infiltration correlates with CXCL10 expression in ganglia of cynomolgus macaques with reactivated simian varicella virus.

Authors:  Werner J D Ouwendijk; Allison Abendroth; Vicki Traina-Dorge; Sarah Getu; Megan Steain; Mary Wellish; Arno C Andeweg; Albert D M E Osterhaus; Don Gilden; Georges M G M Verjans; Ravi Mahalingam
Journal:  J Virol       Date:  2012-12-26       Impact factor: 5.103

9.  Prevalence and distribution of latent simian varicella virus DNA in monkey ganglia.

Authors:  R Mahalingam; P Clarke; M Wellish; A N Dueland; K F Soike; D H Gilden; R Cohrs
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

10.  T-Cell tropism of simian varicella virus during primary infection.

Authors:  Werner J D Ouwendijk; Ravi Mahalingam; Rik L de Swart; Bart L Haagmans; Geert van Amerongen; Sarah Getu; Don Gilden; Albert D M E Osterhaus; Georges M G M Verjans
Journal:  PLoS Pathog       Date:  2013-05-09       Impact factor: 6.823

View more
  10 in total

1.  Reactivation of Simian Varicella Virus in Rhesus Macaques after CD4 T Cell Depletion.

Authors:  Vicki Traina-Dorge; Brent E Palmer; Colin Coleman; Meredith Hunter; Amy Frieman; Anah Gilmore; Karen Altrock; Lara Doyle-Meyers; Maria A Nagel; Ravi Mahalingam
Journal:  J Virol       Date:  2019-01-17       Impact factor: 5.103

2.  Robust gene expression changes in the ganglia following subclinical reactivation in rhesus macaques infected with simian varicella virus.

Authors:  Nicole Arnold; Christine Meyer; Flora Engelmann; Ilhem Messaoudi
Journal:  J Neurovirol       Date:  2017-03-20       Impact factor: 2.643

3.  Simian Varicella Virus Pathogenesis in Skin during Varicella and Zoster.

Authors:  Ravi Mahalingam; Brittany Feia; Colin Coleman; Kusala Anupindi; Pratush Saravanan; Amalia Luthens; Amalia Bustillos; Arpita Das; Eileen de Haro; Lara Doyle-Meyers; Jayme Looper; Andrew N Bubak; Christy S Niemeyer; Brent Palmer; Maria A Nagel; Vicki Traina-Dorge
Journal:  Viruses       Date:  2022-05-27       Impact factor: 5.818

4.  Simian Varicella Virus: Molecular Virology and Mechanisms of Pathogenesis.

Authors:  Allen Jankeel; Izabela Coimbra-Ibraim; Ilhem Messaoudi
Journal:  Curr Top Microbiol Immunol       Date:  2021-10-21       Impact factor: 4.737

Review 5.  Nonhuman primate models of human viral infections.

Authors:  Jacob D Estes; Scott W Wong; Jason M Brenchley
Journal:  Nat Rev Immunol       Date:  2018-06       Impact factor: 53.106

6.  Elevated serum substance P during simian varicella virus infection in rhesus macaques: implications for chronic inflammation and adverse cerebrovascular events.

Authors:  Andrew N Bubak; Vicki Traina-Dorge; Christina N Como; Brittany Feia; Catherine M Pearce; Laura Doyle-Meyers; Arpita Das; Jayme Looper; Ravi Mahalingam; Maria A Nagel
Journal:  J Neurovirol       Date:  2020-09-22       Impact factor: 2.643

7.  Attenuation of Simian Varicella Virus Infection by Enhanced Green Fluorescent Protein in Rhesus Macaques.

Authors:  Ravi Mahalingam; Benedikt B Kaufer; Werner J D Ouwendijk; Georges M G M Verjans; Colin Coleman; Meredith Hunter; Arpita Das; Brent E Palmer; Eric Clambey; Maria A Nagel; Vicki Traina-Dorge
Journal:  J Virol       Date:  2018-03-14       Impact factor: 5.103

Review 8.  Varicella Zoster Virus in the Nervous System.

Authors:  Don Gilden; Maria Nagel; Randall Cohrs; Ravi Mahalingam; Nicholas Baird
Journal:  F1000Res       Date:  2015-11-26

Review 9.  Monocytes and Macrophages as Viral Targets and Reservoirs.

Authors:  Ekaterina Nikitina; Irina Larionova; Evgeniy Choinzonov; Julia Kzhyshkowska
Journal:  Int J Mol Sci       Date:  2018-09-18       Impact factor: 5.923

Review 10.  Current In Vivo Models of Varicella-Zoster Virus Neurotropism.

Authors:  Ravi Mahalingam; Anne Gershon; Michael Gershon; Jeffrey I Cohen; Ann Arvin; Leigh Zerboni; Hua Zhu; Wayne Gray; Ilhem Messaoudi; Vicki Traina-Dorge
Journal:  Viruses       Date:  2019-05-31       Impact factor: 5.048

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.